V
ViroXis
Develops botanical pharmaceuticals derived from sandalwood oil
About ViroXis
Viroxis operates in the global wellness market, focusing on the sustainable supply and commercialization of Sandalwood Album, a unique ingredient with a rich history spanning over 2000 years. The company serves a diverse clientele, including cosmetic manufacturers, wellness brands, and pharmaceutical companies, leveraging the multifaceted benefits of Sandalwood Album. Viroxis's business model revolves around cultivating and harvesting Sandalwood Album sustainably, ensuring a continuous and eco-friendly supply chain. Revenue is generated through the sale of raw sandalwood, processed extracts, and proprietary formulations to various industries. By positioning itself as the world's first and only sustainable supplier of this endangered species, Viroxis taps into the growing demand for natural and ethically sourced wellness ingredients. The company also invests in research and development to explore new applications and benefits of Sandalwood Album, further enhancing its market appeal.
Source: Dealroom company dataAt a glance
- Founded
- 2006
- Headquarters
- San Antonio, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Texas Economic Development Corporation- GAGreer Capital Advisors
Series B and later1 investor entered at this stage
- TFTexas Emerging Technology Fund
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about ViroXis on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ViroXis on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.